Molecular profiles of hepatotoxicity and nephrotoxicity markers in dysmenorrheic (on treatment or not) students
Open Access
- 18 February 2020
- journal article
- Published by Heighten Science Publications Corporation in Clinical Journal of Obstetrics and Gynecology
- Vol. 3 (1), 013-017
- https://doi.org/10.29328/journal.cjog.1001042
Abstract
No abstract availableThis publication has 12 references indexed in Scilit:
- What we know about primary dysmenorrhea today: a critical reviewHuman Reproduction Update, 2015
- Nonsteroidal anti-inflammatory drugs for dysmenorrhoeaEmergencias, 2015
- Malondialdehyde, nitric oxide and adrenomedullin levels in patients with primary dysmenorrheaJournal of Obstetrics and Gynaecology Research, 2008
- Dysmenorrhea: Contemporary PerspectivesObstetrical & Gynecological Survey, 2008
- Clinical efficacy and differential inhibition of menstrual fluid prostaglandin F2α in a randomized, double-blind, crossover treatment with placebo, acetaminophen, and ibuprofen in primary dysmenorrheaAmerican Journal of Obstetrics and Gynecology, 2007
- Dysmenorrhea in Adolescents and Young Adults: Etiology and ManagementJournal of Pediatric and Adolescent Gynecology, 2006
- Primary DysmenorrheaObstetrics & Gynecology, 2006
- Diagnosis and management of dysmenorrhoeaBMJ, 2006
- Why there are two cyclooxygenase isozymesJCI Insight, 2001
- Marine Oils and Their EffectsNutrition Reviews, 1992